Long-term Quality of Life for Patients with Early Stage Uterine Cervical Carcinoma after Treatment

Chinese Journal of Radiology

Volumn 29, Issue 1, 2004, Pages 21-28

  Hsu, Wei Chung ^a   Chung, Na Na ^b   Chen, Yu Chia ^c   Chan, Sue Ching ^d   Ting, Lai Lei ^b   Tsai, Chung Huang ^a   Wang, Hsueh Feng ^a   Wang, Po Ming ^a   Lin, Gau De ^a  

^a CHENG CHING GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

EORTC; Quality of life; Radiotherapy; Uterine cervical cancer

Indexed keywords

APPETITE DISORDER; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COGNITION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; EARLY CANCER; FEMALE; HEALTH STATUS; HOT FLUSH; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; PAIN; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; RADIATION RESPONSE; SOCIAL STATUS; TREATMENT OUTCOME; URINE INCONTINENCE; UTERINE CERVIX CARCINOMA; VAGINA DISCHARGE; VOMITING;

EID: 1842709965     PISSN: 10188940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. JNCI 1993; 85: 365-376
2. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 2001; 111: 1440-1452
3. Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000; 36: 1796-1807
4. Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK. Quality of life and survival. The role of multidimensional symptom assessment. Cancer 1998; 83: 173-179
5. Cooper CL. Self transcendence and emotional wellbeing in women with advanced breast cancer. Oncol Nursing Forum 1991; 18: 857-862
6. The WHOQOL group. Development of World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551-558
7. The WHOQOL group. The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-1409
8. The WHOQOL group. The World Health Organization Quality of Life assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med 1998; 46: 1569-1585
9. (http://www.doh.gov.tw/statistic/index.htm)
10. Perez CA. Uterine cervix. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Third edition. Philadelphia: Lippincott-Raven; 1998: 1733-1834
11. Rubin P, Constine LS, Fajardo LF, et al. RTOG late effects working group. Overview late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995; 31: 1041-1042
12. Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol 2002; 41: 317-325
13. Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int J of Gynecol Cancer 2002; 12: 424-428
14. Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S. Fatigue associated with cancer and its treatment. Supportive Care in Cancer 2002; 10: 389-398
15. Bye A, Ose T, Kaasa S. Quality of life during pelvic radiotherapy. Acta Obstet Gynecol Scand 1995; 74: 147-152
16. Klee M, Thranov I, Machin D. The patients' perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol 2000; 76: 14-23
17. Parkin DE, Davis JA, Symonds RP. Long-term bladder symptomatology following radiotherapy for cervical carcinoma. Radiother Oncol 1987; 9: 195-199
18. Parkin DE, Davis JA, Symonds RP. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol 1988; 61: 213-217
19. Barter JF, Soong SJ, Shingleton HM, et al. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989; 32: 292-296
20. Fiorica JV, Roberts WS, Greenberg H, et al. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990; 36: 343-347
21. Montz FJ, Holschneider CH, Solh S, et al. Small bowel obstruction following radical hysterectomy: Risk factors, incidence, and operative findings. Gynecol Oncol 1994; 53: 114-120
22. Barnes W, Waggoner S, Delgado G, et al. Manometric characterization of rectal dysfunction following radical hysterectomy. Gynecol Oncol 1991; 42: 116-119
23. Magrina JF, Goodrich MA, Weaver AL, et al. Modified radical hysterectomy: Morbidity and mortality. Gynecol Oncol 1995; 59: 277-282
24. Martinbeau PW, Kjorstad KE, Kolstad P. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital, 1968-1970: Results of treatment and major complications. I: Lymphedema. Am J Obstet Gynecol 1978; 131: 389-394
25. Werngren-Elgstrom M, Lidman D. Lymphoedema of the lower extremities after surgery and radiotherapy for cancer of the cervix. Scand J of Plastic & Reconstructive Surg & Hand Surg 1994; 28: 289-293
26. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990; 37: 390-395
27. Farquharson DI, Shingleton HM, Soong SJ, Sanford SP, Levy DS, Hatch KD. The adverse effects of cervical cancer treatment on bladder function. Gynecol Oncol 1987; 27: 15-23
28. Seski JC, Diokno AC. Bladder dysfunction after radical abdominal hysterectomy. Am J Obstet Gynecol 1997; 128: 643-651
29. Zoubek J, McGuire EJ, Noll F, DeLancey JO. The late occurrence of urinary tract damage in patients successfully treated by radiotherapy for cervical carcinoma. J Urol 1989; 141: 1347-1349
30. Anderson B, LaPolla J, Turner D, et al. Ovarian transposition in cervical cancer. Gynecol Oncol 1993; 49: 206-214
31. Feeney DD, Moore DH, Look KY, et al. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 1995; 56: 3-7
32. Crook JM, Esche Ba, Chaplain G, et al. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987; 8: 321-332
33. Eifel PJ, Levenback C, Wharton JT, et al. Time course and incidence of late complication in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995; 32: 1289-1300
34. Bye A, Trope C, Loge JH, Hjermstad M, Kaasa S. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy-evaluation of long-term effects of diagnosis and treatment. Acta Oncologica 2000; 39: 173-180
35. Grigsby PW, Russell A, Bruner D, et al. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 1995; 31: 1281-1299
36. Christman NJ, Oakley MG, Cronin SN. Developing and using preparatory information for women undergoing radiation therapy for cervical or uterine cancer. Oncol Nursing Forum 2001; 28: 93-98
37. Morita K. Cancer of the cervix. In: Vahrson HW, editor. Radiation oncology of gynecological cancers. First edition. Berlin: Springer-Verlag; 1997: 143-239